Asterias Biotherapeutics (AST) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AST Stock Alerts $0.0020 0.00 (0.00%) (As of 07/10/2019) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCLDI Calidi Biotherapeutics, Inc.seekingalpha.com - March 27 at 8:25 AMProtalix BioTherapeutics Inc PLXmorningstar.com - February 17 at 11:04 PMCalidi Biotherapeutics Stock (AMEX:CLDI) Dividends: History, Yield and Datesbenzinga.com - November 27 at 9:49 AMBarinthus Biotherapeutics PLC ADRmorningstar.com - November 22 at 6:14 PMCalidi Biotherapeutics Inc Ordinary Shares - Class Amorningstar.com - November 2 at 12:42 AMArcutis Biotherapeutics Stock (NASDAQ:ARQT), Analyst Ratings, Price Targets, Predictionsbenzinga.com - July 18 at 5:56 PMIovance Biotherapeutics (NASDAQ: IOVA)fool.com - May 21 at 8:16 AMHuman Embryonic Stem Cells (HESC) Market Future Investments and Forecast Till 2030marketwatch.com - May 11 at 9:05 PMBrightPath Biotherapeutics Co Ltd (4594)investing.com - May 8 at 3:29 PMHuman Embryonic Stem Cells (HESC) Market: Analyzing Growth Opportunities and Industry Trends for 2023-2028marketwatch.com - March 14 at 6:50 PM2023-2029 Human Embryonic Stem Cells (HESC) Market Size and Regional Analysis | Research Report by Absolute Reportsmarketwatch.com - March 9 at 8:02 AMStem Cell Therapy for Osteoarthritis Market Expert Industrial Investigation Report 2023-2028marketwatch.com - March 7 at 3:39 AMTherapeutic Cancer Vaccines Market 2023 | Global Industry Report Forecast 2029marketwatch.com - March 6 at 10:38 PMEmerging Opportunities in Therapeutic Cancer Vaccines Market from 2023 to 2027marketwatch.com - February 27 at 7:52 AMAtara Biotherapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - February 20 at 12:18 AMTherapeutic Cancer Vaccines Market Outlook 2023 and Forecast to 2028 with Top Countries Datamarketwatch.com - February 14 at 10:23 AMBridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023finance.yahoo.com - January 30 at 3:03 PMSONN Sonnet BioTherapeutics Holdings, Inc.seekingalpha.com - January 20 at 6:58 PMHuman Embryonic Stem Cells (HESC) Market By Industry Research, Supply, Size, Share and Prospects 2023-2028marketwatch.com - January 19 at 9:05 AMSonnet BioTherapeutics Shares Up 8% on Roche Collaborationmarketwatch.com - January 11 at 8:03 PMKling Biotherapeutics Appoints Michael Koslowski, M.D. As Chief Executive Officerfinance.yahoo.com - January 5 at 7:35 AMSensei Biotherapeutics Slashes Workforce, Closes R&D Sitefinance.yahoo.com - December 20 at 6:29 PMHuman Embryonic Stem Cells (HESC) Market 2022 Statistics, Industry Share, Latest Trends, Growth Drivers, Size Estimate and Forecast till 2028marketwatch.com - November 27 at 8:55 AMHuman Embryonic Stem Cells (HESC) Market 2022 Statistics, Industry Share, Latest Trends, Growth Drivers, Size Estimate and Forecast till 2028marketwatch.com - November 27 at 8:55 AMTherapeutic Cancer Vaccines Market 2023 : SWOT Analysis by Players Continues Explosive Growth by 2028marketwatch.com - November 25 at 11:37 AMAtara, Pierre Fabre Announce CHMP Adopts Positive Opinion Recommending Approval Of Ebvallomarkets.businessinsider.com - October 16 at 3:00 PMTILT Biotherapeutics Announces First US Patient Dosed in Immunotherapy Clinical Trial in Ovarian Cancerfinance.yahoo.com - October 14 at 12:30 PMNavana CNG Ltd (NAVA)investing.com - March 28 at 11:57 PMAsterias Biotherapeutics Inc (AST)investing.com - February 25 at 10:22 PMGlobal Spinal Cord Trauma Treatment Market Price, Vendors, Share, Future Opportunities, Potential Business Strategies Analysis 2022 to 2027marketwatch.com - January 15 at 9:59 PMmRNA Synthesis and Manufacturing Services Markets...benzinga.com - October 14 at 7:27 AMTelomerase Reverse Transcriptase Market Report 2021 Growth Factors, Product Type, Manufacturers, Application, End User and Regions 2027marketwatch.com - August 9 at 9:40 PM Get Asterias Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AST and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> AST Media Mentions By Week AST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AST News Sentiment▼0.000.32▲Average Medical News Sentiment AST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AST Articles This Week▼00▲AST Articles Average Week Get Asterias Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NBY News PKBO News WCUI News PPCB News PRED News BOMH News ABMT News ACUR News STAB News XSNX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:AST) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asterias Biotherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
